A study to evaluate the efficacy of Azilsartan in the treatment of hypertension, in Indian populatio
- Conditions
- Health Condition 1: null- Patients with Hypertension
- Registration Number
- CTRI/2018/05/014285
- Lead Sponsor
- Micro Labs Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Newly diagnosed hypertensive patients.
2.Seated BP of more than 140 mm Hg SBP and 90 mm Hg DBP in subjects who are already on dual drug therapy for at least 1 month.
3.Ability to stop any current antihypertensive therapy without unacceptable risk to the patient (Investigators discretion)
4. Subjects willing to complete all study-related procedures
1. Pregnant or breast feeding women
2. Subjects with serious medical condition
3. Patients with contraindications or hypersensitivity to any component of the formulation
4. Any other clinical condition which, in the opinion of the investigator, would not allow safe completion of the protocol and safe administration of the trial medication
Subjects participating in another investigational drug trial within 4 weeks of trial enrolment.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method